Literature DB >> 1371769

Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.

J Sarwar1, A A Campagnari, C Kirkham, T F Murphy.   

Abstract

Branhamella catarrhalis is a common cause of otitis media in children and of respiratory infections in adults with chronic bronchitis. Little is known about the antigenic structure of the outer membrane proteins (OMPs). In this study, two murine monoclonal antibodies, 7D6 and 5E8, were developed and used to characterize the major heat-modifiable OMP (OMP C/D) of B. catarrhalis. Immunoblot assays indicated that OMP C/D is heat modifiable, having a molecular mass of 55 kDa at room temperature and a mass of 60 kDa when heated under reducing conditions. Expression of the epitopes is independent of growth phase and growth media. Both epitopes are present in 51 of 51 strains of B. catarrhalis tested and are highly specific for Branhamella strains, being absent from a variety of other gram-negative species. Antibody 5E8 recognizes an epitope which is expressed on the surface of the intact bacterium. We conclude that OMP C/D is a major, heat-modifiable OMP antigen that expresses at least one stable, conserved epitope on the surface of B. catarrhalis. Future studies should focus on the role of OMP C/D in pathogenesis and on its potential role as a vaccine antigen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371769      PMCID: PMC257558          DOI: 10.1128/iai.60.3.804-809.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Sinusitis of the maxillary antrum.

Authors:  F O Evans; J B Sydnor; W E Moore; G R Moore; J L Manwaring; A H Brill; R T Jackson; S Hanna; J S Skaar; L V Holdeman; S Fitz-Hugh; M A Sande; J M Gwaltney
Journal:  N Engl J Med       Date:  1975-10-09       Impact factor: 91.245

2.  Phenotypic characteristics of Branhamella catarrhalis strains.

Authors:  J L Soto-Hernandez; S Holtsclaw-Berk; L M Harvill; S L Berk
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

3.  Subacute sinusitis in children.

Authors:  E R Wald; C Byers; N Guerra; M Casselbrant; D Beste
Journal:  J Pediatr       Date:  1989-07       Impact factor: 4.406

Review 4.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

Review 5.  The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen.

Authors:  T F Murphy
Journal:  Pediatr Infect Dis J       Date:  1989-01       Impact factor: 2.129

6.  Antigenic heterogeneity of lipid A of Haemophilus influenzae.

Authors:  M A Apicella; K C Dudas; A Campagnari; P Rice; J M Mylotte; T F Murphy
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Meningitis due to Branhamella catarrhalis.

Authors:  J H O'Neill; P W Mathieson
Journal:  Aust N Z J Med       Date:  1987-04

8.  Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis.

Authors:  L C Bartos; T F Murphy
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

9.  Acute otitis media caused by Branhamella catarrhalis: biology and therapy.

Authors:  G F Van Hare; P A Shurin; C D Marchant; N A Cartelli; C E Johnson; D Fulton; S Carlin; C H Kim
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

10.  Branhamella catarrhalis pneumonia: report of two cases and review of the literature.

Authors:  G Srinivasan; M J Raff; W C Templeton; S J Givens; R C Graves; J C Melo
Journal:  Am Rev Respir Dis       Date:  1981-05
View more
  22 in total

1.  Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis.

Authors:  T F Murphy; C Kirkham; E DeNardin; S Sethi
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Serum antibody response to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchopulmonary infection.

Authors:  J J Christensen; N Q Hansen; B Bruun
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

3.  Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis.

Authors:  R Bhushan; C Kirkham; S Sethi; T F Murphy
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Size variation of the major immunodominant protein of Cowdria ruminantium.

Authors:  A F Barbet; S M Semu; N Chigagure; P J Kelly; F Jongejan; S M Mahan
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

Review 5.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

6.  Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.

Authors:  Dai-Fang Liu; John C McMichael; Steven M Baker
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

7.  Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.

Authors:  Min Yang; Antoinette Johnson; Timothy F Murphy
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

8.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 9.  Mouse models for human otitis media.

Authors:  Dennis R Trune; Qing Yin Zheng
Journal:  Brain Res       Date:  2009-03-06       Impact factor: 3.252

10.  Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production.

Authors:  A A Campagnari; K L Shanks; D W Dyer
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.